Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues

Azar Baradaran ¹ *

Cited by CrossRef: 16

1- Nasri R. Renoprotective effects of metformin. DARU J Pharm Sci. 2013;21(1) [Crossref]

2- Rodriguez V, Chahine A, Parrish M, Alcaide M, Lee T, Hurwitz B, Sawhney M, Weiss S, Jones D, Kumar M. The contribution of syndemic conditions to cardiovascular disease risk. AIDS Care. 2021;33(5):585 [Crossref]

3- Nasri H, Nasri P, Baradaran A, Abedi-Gheshlaghi Z, Rafieian-Kopaei M. World Kidney Day 2016: Awareness for Saving Kidneys. Shiraz E-Med J. 2015;16(9-10) [Crossref]

4- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU J Pharm Sci. 2013;21(1) [Crossref]

5- Zhang S, Xu H, Yu X, Wu Y, Sui D. Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes. 2017;14(1):383 [Crossref]

6- Savira M, Savira R, Syahputra M. Association of serum uric acid level and blood pressure in type 2 diabetes mellitus. IOP Conf Ser: Earth Environ Sci. 2018;125:012169 [Crossref]

7- Zhang J, Shi Q, Hu Y, Li X. Silibinin augments the effect of clopidogrel on atherosclerosis in diabetic ApoE deficiency mice. CH. 2022;80(4):353 [Crossref]

8- Park B. Stages of renal artery stenosis: a hypothesis based on ultrasound findings: A narrative review. Precis Future Med. 2023;7(1):2 [Crossref]

9- Kakavandi N, Rezaee S, Hosseini-Fard S, Ghasempour G, Khosravi M, Shabani M, Najafi M. Prostaglandin E2 (PGE2) synthesis pathway is involved in coronary artery stenosis and restenosis. Gene. 2021;765:145131 [Crossref]

10- Zhang Z, Li L, Shi H, Chen B, Li X, Zhang Y, Liu F, Wei W, Zhou Y, Liu K, Xia W, Gu X, Huang J, Tu S, Yin C, Shao A, Jiang L. Role of Circular RNAs in Atherosclerosis through Regulation of Inflammation, Cell Proliferation, Migration, and Apoptosis: Focus on Atherosclerotic Cerebrovascular Disease. Medicina. 2023;59(8):1461 [Crossref]

11- Haider M, Sahebkar A, Eid A. Selective Activation of G Protein-coupled Estrogen Receptor 1 Attenuates Atherosclerosis. CMC. 2024;31(27):4312 [Crossref]

12- Kathuria D, Raul A, Wanjari P, Bharatam P. Biguanides: Species with versatile therapeutic applications. European Journal of Medicinal Chemistry. 2021;219:113378 [Crossref]

13- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]

14- Rafieian Kopaei M, Baradaran A. Protective Effects of Metformin on Renal Tubular Cells. Iran Red Crescent Med J. 2014;16(9) [Crossref]

15- Fouad A, Ali M, Naguib D, Farouk H, Zanaty M, El-Ela F. Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis. Drug Deliv and Transl Res. 2024;14(2):474 [Crossref]